Figure 3.
Expression of CD39 on CD73- and CD73+ subsets of CD8+T cells and NKT cells in COVID-19 (C19) and healthy donors (HD). PBMCs from COVID-19 patients and HD were analyzed ex vivo in unstimulated cells by flow cytometry. CD39+ cells were significantly elevated on CD73-CD8+ T cells (A) and CD73- NKT cells (B).
